Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-07
1999-02-02
Scheiner, Laurie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241841, 4241851, 4242781, 530324, 530328, 530329, 530350, 530812, A61K 3804, A61K 3929
Patent
active
058661395
ABSTRACT:
This invention relates to purified HCV E1 peptides, immunogenic composition comprising purified HCV E1 peptides, and a diagnostic kit for detecting HCV E1-specific antibodies. The purified HCV E1 peptide has an amino acid selected from the group consisting of SEQ ID NO:3; SEQ ID NO:5; and SEQ ID NO:7.
REFERENCES:
Okamoto et al., The 5'-Terminal Sequence of the Hepatitis C Virus Genome, Japan J. Exp. Med. 60(3) :167-177 (1990).
Weiner et al., Variable and Hypervariable Domains Are Found in the Regions of HCV Corresponding to the Flavivirus Envelope and NS1 Proteins and the Pestivirus Envelope Glycoproteins, Virology 180: 842-848 (1991).
Choo et al., Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome, Science 244:359-362 (1989).
Brechot Christian
Kremsdorf Dina
Porchon Colette
Institut Pasteur
Scheiner Laurie
LandOfFree
Nucleotide and peptide sequences of a hepatitis C virus isolate, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide and peptide sequences of a hepatitis C virus isolate,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide and peptide sequences of a hepatitis C virus isolate, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114688